Why choose Austria for Lutetium-177 therapy?
Access advanced Lutetium-177 therapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Lutetium-177 therapy | from $8,800 | from $35,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lutetium-177 therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lutetium-177 therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lutetium-177 therapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5
Week 1-2 Post Therapy
Week 3-4 Post Therapy
Week 5-6 Post Therapy
Please note that each patient"s case is unique and the timeline may vary.
As the leading global medical tourism platform, we have a huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
For those seeking Lutetium-177 therapy in Austria, we offer a wide range of options and choices to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Written by Kateryna Zamkovska
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Lutetium-177 therapy is a targeted radioligand treatment using radioactive isotopes to destroy advanced cancer cells. This theranostic approach combines diagnostic imaging with precision beta radiation. It primarily treats metastatic castration-resistant prostate cancer and neuroendocrine tumors while sparing surrounding healthy tissue through short-range radiation delivery.
Bookimed Expert Insight: While many global clinics offer Lutetium-177, Austrian facilities like Wiener Privatklinik stand out for their diagnostic integration. They treat over 7,000 patients annually and utilize on-site Aeromedical Centers for same-morning pre-treatment exams. This efficiency significantly reduces the time international patients must stay abroad between diagnostic scans and their first infusion cycle.
Patient Consensus: Patients frequently report that while the treatment effectively reduces pain and lowers PSA levels, managing persistent dry mouth is a common practical challenge. The outpatient nature of the infusions allows for a much faster return to daily routines compared to traditional systemic chemotherapy.
Lutetium-177 therapy in Austria primarily treats advanced, metastatic castration-resistant prostate cancer and neuroendocrine tumors (NETs). Specialized nuclear medicine departments use Lu-177 PSMA to target prostate tumor cells and PRRT (Lutathera) for somatostatin-receptor positive gastroenteropancreatic tumors when surgery is not feasible.
Bookimed Expert Insight: While many countries treat Lutetium-177 as a secondary option, Austrian private clinics like Wiener Privatklinik coordinate these cases through multidisciplinary tumor boards. This ensures patients receive nuclear medicine expertise integrated with standard oncology. Their high volume of 12,000 annual patients supports faster access to specialized ligands like Pluvicto.
Patient Consensus: Patients emphasize that checking receptor status via PET scan is the critical first step. Most report manageable short-term fatigue and emphasize the importance of regular blood count monitoring between infusions.
Candidates for 177Lu-PSMA therapy are adults with advanced metastatic castration-resistant prostate cancer that has progressed after hormone therapy. Successful eligibility depends on high PSMA protein expression confirmed via PET scan and stable organ function to safely process systemic radionuclide radiation.
Bookimed Expert Insight: Austria provides a high-tier clinical environment for this therapy. Facilities like Wiener Privatklinik are globally ranked by Newsweek and focus on complex oncology. While the therapy is life-extending, Austrian specialists prioritize bone marrow health. They often require specific blood count thresholds before each of the 3–4 injections.
Patient Consensus: Patients emphasize that a positive PET scan is the critical first hurdle. Many report that while the treatment effectively manages symptoms, preparing for side effects like dry mouth or fatigue is essential.
Lutetium-177 therapy in Austria is administered via a 10–30 minute intravenous radioactive infusion. Patients first receive a kidney-protective amino-acid drip. Recovery involves 3–14 days of strict radiation precautions. Expect several days of fatigue and nausea as your body processes the radionuclide.
Bookimed Expert Insight: Clinics like Wiener Privatklinik leverage Austria's high global rank in nuclear medicine. Data shows hydration protocols are the biggest differentiator. Comprehensive centers use specific amino-acid blends. These reduce kidney radiation uptake. This protects organ function across multiple treatment cycles.
Patient Consensus: Patients emphasize preparing for a long day of hydration drips before the short infusion. Many recommend bringing books or music and planning for significant fatigue during the first week.
Austria offers Lutetium-177 therapy at specialized nuclear medicine centers in Vienna, Salzburg, and Innsbruck. Leading facilities include Wiener Privatklinik and University Hospital Vienna (AKH). These centers utilize advanced PSMA and DOTATATE radioligand therapies for metastatic prostate cancer and neuroendocrine tumors.
Bookimed Expert Insight: Wiener Privatklinik stands out because it combines private hospital comfort with elite university-level expertise. While AKH serves massive patient volumes, WPK offers 4.6-rated personalized care with 300 specialized doctors. This balance is ideal for international patients seeking fast access to nuclear medicine without the wait times typical of large public research hubs.
Patient Consensus: Patients emphasize that Lutetium-177 requires a multidisciplinary tumor board review rather than routine referral. They advise verifying if a facility has a dedicated nuclear medicine department before booking travel.